Survey of oral propolis effect in patients with type 2 diabetes

Phase 3

• Conditions: Type 2 Diabetes.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2017041019669N4
• Lead Sponsor: Vice chancellor for research, Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

having the type 2 diabetes -voluntary consent for participation in the study
Exclusion criteria: -use of multivitamin-mineral supplements at least 6month before the study -smoking, alcohol abuse -treatment with insulin -having the hepatic, renal failure, cardiovascular, celiac, gastrointestinal, rheumatic

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting Blood Sugar. Timepoint: Before intervention and two months after intervention. Method of measurement: ELISA.;Insulin. Timepoint: Before intervention and two months after intervention. Method of measurement: ELISA.;HbA1c. Timepoint: Before intervention and two months after intervention. Method of measurement: ELISA.;Lipid profile. Timepoint: Before intervention and two months after intervention. Method of measurement: ELISA.;Added at 2017-10-28: Fructosamine. Timepoint: Added at 2017-10-28: Before intervention and 2 month after intervention. Method of measurement: Added at 2017-10-28: Eliza.

Secondary Outcome Measures

Name	Time	Method
Antioxidant indices. Timepoint: Before intervention and two months after intervention. Method of measurement: ELISA.;Added at 2017-10-28: Inflammatory factors. Timepoint: Added at 2017-10-28: Before intervention and 2 month after intervention. Method of measurement: Added at 2017-10-28: Eliza.